Systems pharmacology meets predictive, preventive, personalized and participatory medicine

Pharmacogenomics

Volumn 14, Issue 2, 2013, Pages 119-122

  Jenkins, Sherry L ^a   Maayan, Avi ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

computational biology; drug drug networks; systems biology

Indexed keywords

COMPLEMENTARY DNA; DNA; DRUG; RNA;

APOPTOSIS; CELL LINEAGE; CELL PROLIFERATION; CELL STIMULATION; COST EFFECTIVENESS ANALYSIS; DNA MICROARRAY; DNA SEQUENCE; DRUG APPROVAL; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; HEALTH CARE PLANNING; HEALTH STATUS; HIGH THROUGHPUT SEQUENCING; HUMAN; INFORMATION PROCESSING; INTERNET; MACHINE LEARNING; MEDICINE; METABOLOMICS; MICROBIOME; MOLECULAR MECHANICS; NONHUMAN; PARTICIPATORY RESEARCH; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT PARTICIPATION; PERSONALIZED MEDICINE; PHARMACOLOGY; PLURIPOTENT STEM CELL; PREVENTIVE MEDICINE; PROCESS TECHNOLOGY; REVIEW; RNA SEQUENCE; SINGLE CELL ANALYSIS; SOCIAL MEDIA; SYMPTOMATOLOGY; SYSTEMS BIOLOGY; SYSTEMS PHARMACOLOGY; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME; WEB BROWSER; XENOGRAFT;

COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; GENOME-WIDE ASSOCIATION STUDY; INDIVIDUALIZED MEDICINE; PREVENTIVE MEDICINE; SYSTEMS BIOLOGY;

EID: 84872508370     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.12.186     Document Type: Review

References (19)

1. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat. Rev. Clin. Oncol. 8(3), 184-187 (2011).
2. The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467(7319), 1061-1073 (2010).
3. Chen R, Mias GI, Li-Pook-Than J et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148(6), 1293-1307 (2012).
4. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 449(7164), 804-810 (2007). (Pubitemid 47598620)
5. Lamb J, Crawford ED, Peck D et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795), 1929-1935 (2006). (Pubitemid 44497995)
6. Dannenfelser R, Xu H, Raimond C, Ma'ayan A, MacArthur BD. Network pharmacology to aid the drug discovery process. In: New Frontiers of Network Analysis in Systems Biology. Ma'ayan A, MacArthur BD (Eds). Springer, Dordrecht, The Netherlands, 161-172 (2012).
7. Knudsen T, Martin M, Chandler K, Kleinstreuer N, Judson R, Sipes N. Predictive models and computational toxicology. Methods Mol. Biol. 947, 343-374 (2013).
8. Chen EY, Xu H, Gordonov S, Lim MP, Perkins MH, Ma'ayan A. Expression 2 kinases: mRNA profiling linked to multiple upstream regulatory layers. Bioinformatics 28(1), 105-111 (2012).
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006). (Pubitemid 44233629)
10. Pollack A. Seeking cures, patients enlist mice stand-ins. The New York Times, 25 September (2012).
11. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38(Suppl. 1), D355-D360 (2010).
12. Cami A, Arnold A, Manzi S, Reis B. Predicting adverse drug events using pharmacological network models. Sci. Transl. Med. 3(114), 114ra127 (2011).
13. Tatonetti NP, Denny JC, Murphy SN et al. Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels. Clin. Pharmacol. Ther. 90(1), 133-142 (2011).
14. Berger SI, Ma'ayan A, Iyengar R. Systems pharmacology of arrhythmias. Sci. Signal. 3(118), ra30 (2010).
15. Pople HE, Myers JD, Miller RA. DIALOG: a model of diagnostic logic for internal medicine. In: Proceedings of the 4th International Joint Conference on Artificial Intelligence (Volume 1). Morgan Kaufmann Publishers Inc., CA, USA (1975).
16. Ferrucci D, Brown E, Chu-Carroll J et al. Building Watson: an overview of the DeepQA project. AI Mag. 31(3) 59-79 (2010).
17. Ma'ayan A. Colliding dynamical complex network models: biological attractors versus attractors from material physics. Biophys. J. 103(9), 1816-1817 (2012).
18. The NIH Common Fund Office of Strategic Coordination. Library of Integrated Network-based Cellular Signatures (LINCS). www.commonfund.nih.gov/ lincs
19. US FDA. FDA Adverse Event Reporting System (FAERS) (formerly AERS). www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/ AdverseDrugEffects/default.htm